Tizanidine 2 MG Oral Tablet — RxCUI 313412
RxNorm drug concept · Semantic clinical drug
RxCUI 313412
Semantic clinical drug · SCD
● Current RxNorm concept 69 FDA products
249 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI313412
Official nameTizanidine 2 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astizanidine 2 MG (as tizanidine HCl 2.288 MG) Oral Tablet; tiZANidine HCl 2 MG Oral Tablet
FDA products mapped69
Package NDCs mapped249
Reported Medicaid activity (SDUD)2,188,085 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Tizanidine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It helps manage spasticity, meaning stiff, tight muscles that are hard to control. It wears off quickly, so it is meant for the times and activities when you most need relief.
- Food changes how much tizanidine you absorb, and tablets and capsules react differently. The key is to be consistent, either always with food or always without. Tell me or your pre...
- Dry mouth, sleepiness, tiredness or weakness, and dizziness are the most common. Many people find them mild to moderate. Call your doctor if you faint, see things that are not ther...
- It is best to avoid it. Alcohol raises the amount of tizanidine in your blood and adds to drowsiness and side effects. The same goes for other sedating medicines, so check with me...
🕸️ Concept Web — How Tizanidine 2 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Tizanidine 2 MG Oral Tablet
RxCUI 313412 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Tizanidine
57258IN
-
Tizanidine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Zanaflex
153736BN
-
Zanaflex
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Tizanidine Oral Tablet
374146SCDF -
Tizanidine Oral Product
1162724SCDG -
Tizanidine Pill
1162725SCDG -
Tizanidine Oral Tablet [Zanaflex]
367662SBDF -
Zanaflex Oral Product
1187025SBDG -
Zanaflex Pill
1187026SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Tizanidine Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Tizanidine 2 MG
332441SCDC -
Tizanidine 2 MG Oral Tablet [Zanaflex]
153734SBD -
Tizanidine 2 MG [Zanaflex]
565371SBDC
-
Tizanidine 2 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Tizanidine 2 MG
SCDC · 332441 -
Tizanidine Oral Tablet
SCDF · 374146 -
Tizanidine Oral Product
SCDG · 1162724 -
Tizanidine Pill
SCDG · 1162725
Brand-Name Concepts
-
Tizanidine 2 MG Oral Tablet [Zanaflex]
SBD · 153734 -
Tizanidine 2 MG [Zanaflex]
SBDC · 565371 -
Tizanidine Oral Tablet [Zanaflex]
SBDF · 367662 -
Zanaflex Oral Product
SBDG · 1187025 -
Zanaflex Pill
SBDG · 1187026 -
Zanaflex
BN · 153736
📦 FDA Products & Package NDCs
69 products · 249 package NDCs
249 package NDCs map to RxCUI 313412 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00615-8468-39 | 30 TABLET in 1 BLISTER PACK (0615-8468-39) | tizanidine | NCS HealthCare of KY, LLC dba Vangard Labs | 2023-05-10 |
| 00615-8469-39 | 30 TABLET in 1 BLISTER PACK (0615-8469-39) | tizanidine | NCS HealthCare of KY, LLC dba Vangard Labs | 2023-05-10 |
| 16714-0171-01 | 150 TABLET in 1 BOTTLE (16714-171-01) | Tizanidine | NorthStar Rx LLC | 2021-06-15 |
| 16714-0172-01 | 150 TABLET in 1 BOTTLE (16714-172-01) | Tizanidine | NorthStar Rx LLC | 2021-06-15 |
| 16714-0172-02 | 1000 TABLET in 1 BOTTLE (16714-172-02) | Tizanidine | NorthStar Rx LLC | 2021-06-15 |
| 29300-0168-05 | 500 TABLET in 1 BOTTLE, PLASTIC (29300-168-05) | Tizanidine | Unichem Pharmaceuticals (USA), Inc. | 2013-04-01 |
| 29300-0168-10 | 1000 TABLET in 1 BOTTLE, PLASTIC (29300-168-10) | Tizanidine | Unichem Pharmaceuticals (USA), Inc. | 2013-04-01 |
| 29300-0168-15 | 150 TABLET in 1 BOTTLE, PLASTIC (29300-168-15) | Tizanidine | Unichem Pharmaceuticals (USA), Inc. | 2013-04-01 |
| 29300-0168-19 | 90 TABLET in 1 BOTTLE, PLASTIC (29300-168-19) | Tizanidine | Unichem Pharmaceuticals (USA), Inc. | 2023-01-06 |
| 29300-0169-03 | 300 TABLET in 1 BOTTLE, PLASTIC (29300-169-03) | Tizanidine | Unichem Pharmaceuticals (USA), Inc. | 2013-04-01 |
| 29300-0169-05 | 500 TABLET in 1 BOTTLE, PLASTIC (29300-169-05) | Tizanidine | Unichem Pharmaceuticals (USA), Inc. | 2013-04-01 |
| 29300-0169-10 | 1000 TABLET in 1 BOTTLE, PLASTIC (29300-169-10) | Tizanidine | Unichem Pharmaceuticals (USA), Inc. | 2013-04-01 |
| 29300-0169-15 | 150 TABLET in 1 BOTTLE, PLASTIC (29300-169-15) | Tizanidine | Unichem Pharmaceuticals (USA), Inc. | 2013-04-01 |
| 29300-0169-19 | 90 TABLET in 1 BOTTLE, PLASTIC (29300-169-19) | Tizanidine | Unichem Pharmaceuticals (USA), Inc. | 2023-01-06 |
| 35356-0662-30 | 30 TABLET in 1 BOTTLE (35356-662-30) | Tizanidine | Quality Care Products, LLC | 2007-02-06 |
| 35356-0662-60 | 60 TABLET in 1 BOTTLE (35356-662-60) | Tizanidine | Quality Care Products, LLC | 2007-02-06 |
| 35356-0662-90 | 90 TABLET in 1 BOTTLE (35356-662-90) | Tizanidine | Quality Care Products, LLC | 2007-02-06 |
| 43063-0868-12 | 12 TABLET in 1 BOTTLE, PLASTIC (43063-868-12) | Tizanidine | PD-Rx Pharmaceuticals, Inc. | 2018-07-09 |
| 43063-0868-30 | 30 TABLET in 1 BOTTLE, PLASTIC (43063-868-30) | Tizanidine | PD-Rx Pharmaceuticals, Inc. | 2018-07-09 |
| 43063-0868-60 | 60 TABLET in 1 BOTTLE, PLASTIC (43063-868-60) | Tizanidine | PD-Rx Pharmaceuticals, Inc. | 2018-07-09 |
| 50090-0811-00 | 30 TABLET in 1 BOTTLE (50090-0811-0) | Tizanidine | A-S Medication Solutions | 2014-11-28 |
| 50090-0811-01 | 60 TABLET in 1 BOTTLE (50090-0811-1) | Tizanidine | A-S Medication Solutions | 2021-03-15 |
| 50090-0840-00 | 120 TABLET in 1 BOTTLE (50090-0840-0) | Tizanidine | A-S Medication Solutions | 2014-11-28 |
| 50090-0840-02 | 60 TABLET in 1 BOTTLE (50090-0840-2) | Tizanidine | A-S Medication Solutions | 2014-11-28 |
| 50090-0840-03 | 15 TABLET in 1 BOTTLE (50090-0840-3) | Tizanidine | A-S Medication Solutions | 2014-11-28 |
| 50090-0840-04 | 30 TABLET in 1 BOTTLE (50090-0840-4) | Tizanidine | A-S Medication Solutions | 2014-11-28 |
| 50090-0840-06 | 90 TABLET in 1 BOTTLE (50090-0840-6) | Tizanidine | A-S Medication Solutions | 2014-11-28 |
| 50090-0840-07 | 14 TABLET in 1 BOTTLE (50090-0840-7) | Tizanidine | A-S Medication Solutions | 2014-11-28 |
| 50090-2078-00 | 30 TABLET in 1 BOTTLE (50090-2078-0) | Tizanidine | A-S Medication Solutions | 2015-10-08 |
| 50090-2078-01 | 60 TABLET in 1 BOTTLE (50090-2078-1) | Tizanidine | A-S Medication Solutions | 2015-10-08 |
| 50090-2078-02 | 90 TABLET in 1 BOTTLE (50090-2078-2) | Tizanidine | A-S Medication Solutions | 2015-10-08 |
| 50090-7716-00 | 30 TABLET in 1 BOTTLE (50090-7716-0) | tizanidine | A-S Medication Solutions | 2025-10-15 |
| 50090-7716-01 | 60 TABLET in 1 BOTTLE (50090-7716-1) | tizanidine | A-S Medication Solutions | 2025-10-15 |
| 50268-0759-15 | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-759-15) / 1 TABL... | Tizanidine | AvPAK | 2017-08-24 |
| 50268-0760-15 | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-760-15) / 1 TABL... | Tizanidine | AvPAK | 2017-08-24 |
| 55111-0179-03 | 300 TABLET in 1 BOTTLE (55111-179-03) | Tizanidine | Dr. Reddy's Laboratories Limited | 2002-07-03 |
| 55111-0179-10 | 1000 TABLET in 1 BOTTLE (55111-179-10) | Tizanidine | Dr. Reddy's Laboratories Limited | 2002-07-03 |
| 55111-0179-15 | 150 TABLET in 1 BOTTLE (55111-179-15) | Tizanidine | Dr. Reddy's Laboratories Limited | 2002-07-03 |
| 55111-0179-30 | 30 TABLET in 1 BOTTLE (55111-179-30) | Tizanidine | Dr. Reddy's Laboratories Limited | 2002-07-03 |
| 55111-0180-03 | 300 TABLET in 1 BOTTLE (55111-180-03) | Tizanidine | Dr. Reddy's Laboratories Limited | 2002-07-03 |
| 55111-0180-10 | 1000 TABLET in 1 BOTTLE (55111-180-10) | Tizanidine | Dr. Reddy's Laboratories Limited | 2002-07-03 |
| 55111-0180-15 | 150 TABLET in 1 BOTTLE (55111-180-15) | Tizanidine | Dr. Reddy's Laboratories Limited | 2002-07-03 |
| 55111-0180-30 | 30 TABLET in 1 BOTTLE (55111-180-30) | Tizanidine | Dr. Reddy's Laboratories Limited | 2002-07-03 |
| 57664-0502-18 | 1000 TABLET in 1 BOTTLE (57664-502-18) | Tizanidine | Sun Pharmaceutical Industries, Inc. | 2003-12-11 |
| 57664-0502-89 | 150 TABLET in 1 BOTTLE (57664-502-89) | Tizanidine | Sun Pharmaceutical Industries, Inc. | 2003-12-11 |
| 57664-0503-18 | 1000 TABLET in 1 BOTTLE (57664-503-18) | Tizanidine | Sun Pharmaceutical Industries, Inc. | 2003-12-11 |
| 57664-0503-89 | 150 TABLET in 1 BOTTLE (57664-503-89) | Tizanidine | Sun Pharmaceutical Industries, Inc. | 2003-12-11 |
| 60505-0251-01 | 100 TABLET in 1 BOTTLE (60505-0251-1) | tizanidine | Apotex Corp. | 2004-01-16 |
| 60505-0251-02 | 1000 TABLET in 1 BOTTLE (60505-0251-2) | tizanidine | Apotex Corp. | 2004-01-16 |
| 60505-0251-03 | 150 TABLET in 1 BOTTLE (60505-0251-3) | tizanidine | Apotex Corp. | 2004-01-16 |
Observed labelers:
Asclemed USA, Inc. (53) ·
Bryant Ranch Prepack (46) ·
A-S Medication Solutions (13) ·
HAWAII REPACK, INC. (12) ·
Advanced Rx of Tennessee, LLC (10) ·
Advanced Rx Pharmacy of Tennessee, LLC (10)
· +23 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.